« Back
Home /
Capecitabine

Capecitabine

Manufacturer	MedChem Express
Category	Metabolism Cholesterol & Lipid Metabolism Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	1 g
Item no.	HY-B0016-1g
Targets	DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog; Apoptosis
CASRN	154361-50-9
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	359.35
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	DMSO : 250 mg/mL (ultrasonic)\|H2O : ≥ 33.33 mg/mL
Manufacturers Target	Apoptosis; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog
Pathway	Apoptosis; Cell Cycle/DNA Damage
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0016-1g-safety-datasheet.pdf